The strong protective effect of circumcision against cancer of the penis
Male circumcision protects against cancer of the penis, the invasive form of which is a
devastating disease confined almost exclusively to uncircumcised men. Major etiological …
devastating disease confined almost exclusively to uncircumcised men. Major etiological …
Prevalence of human papillomavirus in head and neck cancers in European populations: a meta-analysis
S Abogunrin, GL Di Tanna, S Keeping, S Carroll… - BMC cancer, 2014 - Springer
Background Infection with human papillomavirus (HPV) is necessary for the development of
cervical carcinoma. By contrast, the role of HPV in the pathogenesis of other malignancies …
cervical carcinoma. By contrast, the role of HPV in the pathogenesis of other malignancies …
Modeling preventative strategies against human papillomavirus-related disease in developed countries
K Canfell, H Chesson, SL Kulasingam, J Berkhof… - Vaccine, 2012 - Elsevier
Over the last 5 years, prophylactic vaccination against human papillomavirus (HPV) in pre-
adolescent females has been introduced in most developed countries, supported by …
adolescent females has been introduced in most developed countries, supported by …
The cost effectiveness of human papillomavirus vaccines: a systematic review
K Seto, F Marra, A Raymakers, CA Marra - Drugs, 2012 - Springer
Introduction: Human papillomavirus (HPV) is one of the world's most common sexually
transmitted infections, and has been associated with a number of cervical and non-cervical …
transmitted infections, and has been associated with a number of cervical and non-cervical …
Public health value of universal HPV vaccination
RA Audisio, G Icardi, AM Isidori, CA Liverani… - Critical reviews in …, 2016 - Elsevier
Abstract Background The story of Human Papillomavirus vaccination demands reflection not
only for its public health impact on the prophylactic management of HPV disease, but also …
only for its public health impact on the prophylactic management of HPV disease, but also …
[HTML][HTML] Prophylactic HPV vaccines: current knowledge of impact on gynecologic premalignancies
DM Harper, KB Williams - Discovery Medicine, 2010 - discoverymedicine.com
Approaches for cervical cancer prevention are changing. Screening still remains the most
effective method for cervical cancer prevention. Guidelines are moving to an older group of …
effective method for cervical cancer prevention. Guidelines are moving to an older group of …
The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey
F Dorleans, C Giambi, L Dematte, S Cotter… - …, 2010 - eurosurveillance.org
The Venice 2 human papillomavirus vaccination survey evaluates the state of introduction of
the HPV vaccination into the national immunisation schedules in the 29 participating …
the HPV vaccination into the national immunisation schedules in the 29 participating …
Human papillomavirus (HPV) vaccine policy and evidence-based medicine: Are they at odds?
L Tomljenovic, CA Shaw - Annals of medicine, 2013 - Taylor & Francis
All drugs are associated with some risks of adverse reactions. Because vaccines represent a
special category of drugs, generally given to healthy individuals, uncertain benefits mean …
special category of drugs, generally given to healthy individuals, uncertain benefits mean …
Understanding differences in predictions of HPV vaccine effectiveness: A comparative model-based analysis
N Van de Velde, M Brisson, MC Boily - Vaccine, 2010 - Elsevier
Mathematical models of HPV vaccine effectiveness and cost-effectiveness have produced
conflicting results. The aim of this study was to use mathematical models to compare and …
conflicting results. The aim of this study was to use mathematical models to compare and …
Cost‐effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing
J van Rosmalen, I De Kok… - BJOG: An International …, 2012 - Wiley Online Library
Please cite this paper as: van Rosmalen J, de Kok I, van Ballegooijen M. Cost‐effectiveness
of cervical cancer screening: cytology versus human papillomavirus DNA testing. BJOG …
of cervical cancer screening: cytology versus human papillomavirus DNA testing. BJOG …